FDA To Study Talcum Powder Ovarian Cancer Risks After Thousands of Talcum Powder lawsuits Claim Women Developed Ovarian Cancer
With more than 3,000 Talcum Powder ovarian cancer lawsuits pending litigation, the FDA has decided to investigate the potential link between talcum powered use and ovarian cancer. The U.S. Food and Drug Administration’s (FDA) Office of Women’s Health (OWH) is weighing in on the matter with plans to fund a study that addresses the potential ovarian cancer risk from talc based products.
The talcum powder ovarian cancer lawsuits filed in state in federal courts around the country all allege Johnson & Johnson’s (J&J) talcum powder products cause ovarian cancer in women who consistently use the products in their feminine hygiene routine. J&J asserts that their talcum powder products are safe and does not cause ovarian cancer.
As more consumers are becoming aware of issues involving the potential link between talcum powder and ovarian cancer, the attorneys at Southern Med Law have been speaking with women and their survivors who have contacted the firm with their concerns.
“We continue to evaluate claims regarding women who say they have been diagnosed with ovarian cancer after using J&J’s talcum powder products over an extended period of time,” says Dr. François Blaudeau, founder of Southern Med Law, who is an attorney and a practicing obstetrician/ gynecologist.
Southern Med Law urges women who believe they developed ovarian cancer due to long-term use of Johnson & Johnson’s Shower to Shower or Baby Powder to contact Southern Med Law at 1-205-547-5525 to discuss their legal rights and for a free talcum powder cancer lawsuit review. You can visit southernmedlaw.com for more information.
The majority of ovarian cancer lawsuits have been filed in the 22nd Circuit Court in St. Louis, Missouri where jurors awarded a combined $197 million to three plaintiffs in 2016. J&J lost the first three talcum powered lawsuit trials when jury verdicts found in favor of the women and their families who filed complaints after being diagnosed with ovarian cancer. In October a jury ordered J&J to pay a California woman $70 million In May, a St. Louis jury awarded $55 million to a South Dakota woman who was diagnosed with ovarian cancer following years of genital talcum powder use, and in February, another St. Louis jury reached a verdict that awarded $72 million to the family of an Alabama woman who died after using Johnson & Johnson talcum powders for over 30 years. The majority of ovarian cancer lawsuits have been filed in the 22nd Circuit Court in St. Louis, Missouri where jurors awarded a combined $197 million to three plaintiffs in 2016. All of the complaints filed against J&J accuse the company of failing to adequately warn consumers about the cancer risk associated with talcum powder.
Although there have been epidemiologic and animal studies that examined the association between talc and ovarian cancer, the effect of talc on the female genital system tissues have not been adequately investigated, the FDA said. A study was published in 2009 that examined carcinogenic effects of long-term talc exposure on the genital system of female Sprague -Dawley rats. The preliminary results showed “unfavorable effects on the female genital system,” but these effects seemed to be in the form of foreign body reactions or infections. “This suggests the need for studies with longer exposure periods and more detailed evaluation of the early events in genital system tissue transformation,” the FDA’s announcement said. The proposed research will help to “fill some of the existing gaps in the molecular and genetic events” associated with early formation of ovarian cancer, which are largely unknown, the FDA said.
J&J said in its 2016 annual report to the U.S. Securities and Exchange Commission that 3,100 talcum powder lawsuits are pending against the company. Talcum powder cancer cases have been consolidated for coordinated pretrial proceedings in New Jersey’s Atlantic County Superior Court, Los Angeles County Superior Court in California, and the U.S. District Court, District of New Jersey. The majority of lawsuits have been filed in the 22nd Circuit Court in St. Louis, Missouri where jurors awarded a combined $197 million to three plaintiffs in 2016. All of the complaints filed against J&J accuse the company of failing to adequately warn consumers about the cancer risk associated with talcum powder.
About Southern Med Law And Filing A Talcum Powder Cancer Lawsuit
Southern Med Law is led by Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist. The firm’s legal staff possess a deep understanding of the complex medical and legal questions at issue in talcum powder ovarian cancer lawsuits. Southern Med Law’s attorneys are not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.
Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: (205) 547-5525
Fax: (205) 547-5526
Medical Negligence/MedicalDevice/Pharma/Qui Tam